Ignite Creation Date:
2024-05-05 @ 10:09 PM
Last Modification Date:
2024-10-26 @ 10:14 AM
Study NCT ID:
NCT01047475
Status:
COMPLETED
Last Update Posted:
2015-05-13
First Post:
2009-12-22
Brief Title:
A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer FDA IND 103675
Sponsor:
Microbio Co Ltd
Organization:
Microbio Co Ltd
Study Overview
Official Title:
A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind parallel group placebo-controlled study evaluate the preliminary efficacy and safety of MB-6 320 mgcapsule 6 capsules tid versus placebo in addition to standard chemotherapy in the treatment of patients with metastatic colorectal cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None